| Bioactivity | GSK2838232 inhibit HIV reverse transcriptase activity across a broad panel of HIV-1 isolates, extracted from patent WO/2013090664A1, compound51. | ||||||||||||
| Name | GSK2838232 | ||||||||||||
| CAS | 1443460-91-0 | ||||||||||||
| Formula | C48H73ClN2O6 | ||||||||||||
| Molar Mass | 809.56 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Hatcher Mark Andrew, et al. Preparation of betulin derivatives for the treatment of HIV. From PCT Int. Appl. (2013), WO 2013090664 A1 20130620. |
GSK2838232
CAS: 1443460-91-0 F: C48H73ClN2O6 W: 809.56
GSK2838232 inhibit HIV reverse transcriptase activity across a broad panel of HIV-1 isolates, extracted from patent WO/2
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.